Search Menu
The Institute of Applied Health Sciences

Professor David Price

Professor David Price
Professor David Price
Professor David Price

Chair of Primary Care Respiratory Med

About
Email Address
d.price@abdn.ac.uk
Telephone Number
+44 (0)1224 437237
School/Department
School of Medicine, Medical Sciences and Nutrition
Publications

Page 16 of 86 Results 151 to 160 of 858

  • Correspondence to Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus

    Smith, P. K., Lesslar, O., Price, D. B.
    Allergy, vol. 77, no. 8, pp. 2571-2573
    Contributions to Journals: Letters

  • COPD Population in US Primary Care: Data From the Optimum Patient Care DARTNet Research Database and the Advancing the Patient Experience in COPD Registry

    Pace, W. D., Brandt, E., Carter, V. A., Chang, K., Edwards, C. L., Evans, A., Fox, C., Gaona, G., Han, M. K., Kaplan, A., Kent, R., Kocks, J. W. H., Kruszyk, M., Le Lievre, C. E., Li Voti, T., Mahle, C., Make, B., Ratigan, A. R., Shaikh, A., Skolnik, N., Stanley, B., Yawn, B. P., Price, D.
    Annals of Family Medicine, vol. 20, no. 4, pp. 319-327
    Contributions to Journals: Articles

  • Oral corticosteroid (OCS) risk predictor for Type II Diabetes in asthma

    Stanley, B., Menzies-Gow, A., Bourdin, A., Canonica, G. W., Gurnell, M., Reddel, H. K., Heaney, L. G., Carter, V., Chapaner, J., Tran, T. N., Maslova, E., Maslova, E., Price, D.
    European Respiratory Society (ERS) International Congress.
    Contributions to Conferences: Abstracts

  • A Response to: Letter to the Editor Regarding “Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab”

    Menzies-Gow, A., Hoyte, F. L., Price, D. B., Cohen, D., Barker, P., Kreindler, J., Jison, M., Brooks, C. L., Papeleu, P., Katial, R.
    Advances in Therapy, vol. 39, no. 8, pp. 3862-3865
    Contributions to Journals: Letters

  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    Aspen Allergy Conference – 40th Meeting
    Contributions to Conferences: Abstracts

  • Persistent OCS reduction regardless of starting OCS dose in patients with severe, OCS-dependent asthma treated with dupilumab: LIBERTY ASTHMA TRAVERSE study

    Cosio, B. G., Domingo, C., Gurnell, M., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    15º Congreso ALAT 2022
    Contributions to Conferences: Abstracts

  • Characterisation of the Australian adult population living with asthma: Severe exacerbation frequency, long-term OCS use and adverse effects.

    Hancock, K. L., Bosnic-Anticevich, S. Z., Blakey, J., Hew, M., Chung, L. P., Cvetkovski, B., Claxton, S., Del Fante, P., Denton, E., Doan, J., Ranasinghe, K., Morgan, L., Sharma, A., Smith, P. K., Stewart, D., Thompson, P. J., Wiseman, R., Upham, J. W., Yan, K. Y., Carter, V., Dhillon, K., Heraud, F., Le, T., Vella, R., Price, D.
    Pragmatic and Observational Research, vol. 2022, pp. 43-58
    Contributions to Journals: Articles

  • Healthcare resource utilisation associated with intermittent oral corticosteroid use in asthma

    Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., Chapaneri, J., Henley, W., Carter, V., Shi Kai Chan, J., Ariti, C., Haughney, J., Price, D.
    EAACI HYBRID CONGRESS 2022
    Contributions to Conferences: Abstracts

  • Biologics in severe asthma: the role of real-world evidence from registries

    Paoletti, G., Pepys, J., Casini, M., Di Bona, D., Heffler, E., Goh, C. Y., Price, D. B., Canonica, G. W.
    European Respiratory Review, vol. 31, no. 164, 210278
    Contributions to Journals: Articles

  • Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

    Gurnell, M., Domingo, C., Rabe, K. F., Menzies-Gow, A., Price, D., Brusselle, G., Wechsler, M. E., Xia, C., Djandji, M., Gall, R., Jacob-Nara, J. A., Rowe, P. J., Deniz, Y., Siddiqui, S.
    2022 AANP National Conference
    Contributions to Conferences: Posters
Show 10 | 25 | 50 | 100 results per page

Refine

Chapters in Books, Reports and Conference Proceedings

Contributions to Conferences

Contributions to Journals

Contributions to Specialist Publications

Working Papers

Other Contributions

Update